Back to GetFilings.com




UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

(Mark One)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the quarterly period ended June 30, 2004.

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the transition period from              to             .

 

Commission File Number 001-16537

 


 

ORASURE TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in Its Charter)

 


 

DELAWARE   36-4370966

(State or Other Jurisdiction of

Incorporation or Organization)

 

(IRS Employer

Identification No.)

220 East First Street, Bethlehem, Pennsylvania   18015
(Address of Principal Executive Offices)   (Zip code)

 

(610) 882-1820

(Registrant’s Telephone Number, Including Area Code)

 


 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

Number of shares of Common Stock, par value $.000001 per share, outstanding as of July 30, 2004: 44,531,038

 



          Page No.

     PART I. FINANCIAL INFORMATION     

Item 1.

   Financial Statements (unaudited)    3
     Balance Sheets at June 30, 2004 and December 31, 2003    3
     Statements of Operations for the three months and six months ended June 30, 2004 and 2003    4
     Statements of Cash Flows for the six months ended June 30, 2004 and 2003    5
     Notes to Financial Statements    6

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    12

Item 3.

   Quantitative and Qualitative Disclosures About Market Risk    28

Item 4.

   Controls and Procedures    28

PART II. OTHER INFORMATION

Item 1.

   Legal Proceedings    29

Item 4.

   Submission of Matters to a Vote of Security Holders    29

Item 5.

   Other Information    29

Item 6.

   Exhibits and Reports on Form 8-K    29
     Signatures    31

 

2


Item 1. FINANCIAL STATEMENTS

 

ORASURE TECHNOLOGIES, INC.

BALANCE SHEETS

(Unaudited)

 

     June 30, 2004

    December 31, 2003

 

ASSETS

                

CURRENT ASSETS:

                

Cash and cash equivalents

   $ 13,436,835     $ 30,695,177  

Short-term investments

     52,603,352       33,328,610  

Accounts receivable, net of allowance for doubtful accounts of $183,839 and $359,158

     6,808,832       8,233,869  

Inventories

     4,762,765       4,003,519  

Prepaid expenses and other

     987,089       922,820  
    


 


Total current assets

     78,598,873       77,183,995  

PROPERTY AND EQUIPMENT, net

     6,140,095       6,471,209  

PATENTS AND PRODUCT RIGHTS, net

     2,454,057       1,886,171  

OTHER ASSETS

     589,765       609,932  
    


 


     $ 87,782,790     $ 86,151,307  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY

                

CURRENT LIABILITIES:

                

Current portion of long-term debt

   $ 1,130,151     $ 1,126,423  

Accounts payable

     1,842,631       3,511,148  

Accrued expenses

     7,693,042       5,375,851  
    


 


Total current liabilities

     10,665,824       10,013,422  
    


 


LONG-TERM DEBT

     1,889,082       2,456,454  
    


 


OTHER LIABILITIES

     238,140       172,142  
    


 


COMMITMENTS AND CONTINGENCIES

                

STOCKHOLDERS’ EQUITY:

                

Preferred stock, par value $.000001, 25,000,000 shares authorized, none issued

     —         —    

Common stock, par value $.000001, 120,000,000 shares authorized, 44,530,565 and 44,260,931 shares issued and outstanding

     45       44  

Additional paid-in capital

     209,535,520       204,867,765  

Deferred compensation

     (3,592,713 )     (614,515 )

Accumulated other comprehensive loss

     (362,719 )     (173,704 )

Accumulated deficit

     (130,590,389 )     (130,570,301 )
    


 


Total stockholders’ equity

     74,989,744       73,509,289  
    


 


     $ 87,782,790     $ 86,151,307  
    


 


 

The accompanying notes are an integral part of these statements.

 

3


ORASURE TECHNOLOGIES, INC.

STATEMENTS OF OPERATIONS

(Unaudited)

 

     Three Months Ended June 30,

   

Six Months Ended June 30,


 
     2004

    2003

    2004

    2003

 

REVENUES:

                                

Product

   $ 13,122,039     $ 9,437,555     $ 25,410,907     $ 17,780,519  

Licensing and product development

     92,674       191,303       212,414       458,975  
    


 


 


 


       13,214,713       9,628,858       25,623,321       18,239,494  

COST OF PRODUCTS SOLD

     5,524,736       3,820,875       10,715,266       7,400,991  
    


 


 


 


Gross profit

     7,689,977       5,807,983       14,908,055       10,838,503  
    


 


 


 


COSTS AND EXPENSES:

                                

Research and development

     1,513,617       1,965,275       3,280,774       4,019,986  

Sales and marketing

     3,780,765       2,737,397       7,431,481       4,972,534  

General and administrative

     2,446,174       1,657,369       4,572,146       3,522,990  
    


 


 


 


       7,740,556       6,360,041       15,284,401       12,515,510  
    


 


 


 


Operating loss

     (50,579 )     (552,058 )     (376,346 )     (1,677,007 )

INTEREST EXPENSE

     (39,981 )     (47,208 )     (71,394 )     (95,813 )

INTEREST INCOME

     230,022       83,373       435,781       168,946  

FOREIGN CURRENCY GAIN (LOSS)

     7,625       (3,796 )     1,332       (3,796 )
    


 


 


 


Income (loss) before income taxes

     147,087       (519,689 )     (10,627 )     (1,607,670 )

INCOME TAXES

     4,961       10,564       9,461       15,443  
    


 


 


 


NET INCOME (LOSS)

   $ 142,126     $ (530,253 )   $ (20,088 )   $ (1,623,113 )
    


 


 


 


EARNINGS (LOSS) PER SHARE:

                                

BASIC

   $ 0.00     $ (0.01 )   $ (0.00 )   $ (0.04 )
    


 


 


 


DILUTED

   $ 0.00     $ (0.01 )   $ (0.00 )   $ (0.04 )
    


 


 


 


WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING:

                                

BASIC

     44,465,017       38,412,351       44,368,443       38,330,924  
    


 


 


 


DILUTED

     45,334,105       38,412,351       44,368,443       38,330,924  
    


 


 


 


 

The accompanying notes are an integral part of these statements.

 

4


ORASURE TECHNOLOGIES, INC.

STATEMENTS OF CASH FLOWS

(Unaudited)

 

     Six Months Ended June 30,

 
     2004

    2003

 

OPERATING ACTIVITIES:

                

Net loss

   $ (20,088 )   $ (1,623,113 )

Adjustments to reconcile net loss to net cash provided by operating activities:

                

Stock based compensation expense

     197,952       33,900  

Depreciation and amortization

     1,204,290       1,269,505  

Loss on disposition of property and equipment

     6,599       —    

Write-off of inventory

     327,866       328,412  

Changes in assets and liabilities:

                

Accounts receivable

     1,425,037       (1,116,775 )

Inventories

     (1,087,112 )     (410,189 )

Prepaid expenses and other assets

     (64,269 )     234,088  

Accounts payable and accrued expenses

     (112,410 )     1,557,330  
    


 


Net cash provided by operating activities

     1,877,865       273,158  
    


 


INVESTING ACTIVITIES:

                

Purchases of short-term investments

     (36,322,110 )     (10,181,924 )

Proceeds from the sale of short-term investments

     16,874,400       7,048,399  

Purchases of property and equipment

     (599,789 )     (730,844 )

Purchase of patent and product rights

     —         (250,000 )

Increase in other assets

     (623 )     (450 )
    


 


Net cash used in investing activities

     (20,048,122 )     (4,114,819 )
    


 


FINANCING ACTIVITIES:

                

Borrowings of term debt

     —         211,590  

Repayments of term debt

     (563,644 )     (541,373 )

Proceeds from issuance of common stock

     1,491,606       1,518,996  
    


 


Net cash provided by financing activities

     927,962       1,189,213  
    


 


EFFECT OF FOREIGN EXCHANGE RATE CHANGES ON CASH

     (16,047 )     18,634  
    


 


NET DECREASE IN CASH AND CASH EQUIVALENTS

     (17,258,342 )     (2,633,814 )

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

     30,695,177       4,364,308  
    


 


CASH AND CASH EQUIVALENTS, END OF PERIOD

   $ 13,436,835     $ 1,730,494